WAUKESHA — House Antitrust Subcommittee Chairman David N. Cicilline, D-R.I., and ranking member Jim Sensenbrenner, R-Wis., introduced legislation that would lower the cost of prescription drugs.
The bipartisan bill is known as Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act, according to a press release. The bill would promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products. According to a press release, the bill would also prohibitpharmaceutical and biologic
companies from engaging in anti-competitive conduct that blocks lowercost generic drugs from entering the market.
Sensenbrenner said the bill will implement marketbased solutions making prescription drugs more affordable and save taxpayer money in the process.
“Americans of all ages are burdened by high prescription drug prices, and we must address this growing issue,” Sensenbrenner said Cicilline added that people shouldn’t go broke because they cannot ford the cost of their prescription drugs.
“What pharmaceutical companies are doing is
unconscionable,” Cicilline said. “It needs to end.”
CREATES is co-sponsored by House Judiciary Committee Chairman Jerrold Nadler, D-N.Y., Ranking Member Doug Collins, R-Ga., Congressman Peter Welch, D-Vt., and Congressman David B. McKinley, R-W.Va. An identical version of the bill was introduced in the Senate by Senators Patrick Leahy, DVt., Chuck Grassley, R-Iowa., Amy Klobuchar, D-Minn. and Mike Lee, R-Utah.